The Guide to Raising Institutional Private Capital is a comprehensive course designed to teach biotech CEOs and CFOs of companies that have already raised a Series A and are preparing for a Series B ...

The "Product & Company Valuation" course is designed to teach a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals, or strategic ...

DNA-Based Diagnostics Primer is the ultimate guide to the molecular science behind standard diagnostic tools used in research and clinical settings. This primer breaks down the critical technology ...

From pandemic preparedness to food security, climate change to resource scarcity, the world requires innovative solutions to the challenges facing society. With its potential to create a diverse and ...

Washington, DC, May 28, 2025 – The Biotechnology Innovation Organization (BIO) today announced plans to dedicate its focus entirely to human health and to transition the work of its Agriculture and ...

Medical Device Approval Primer takes a close look at the complex world of regulatory approval pathways. With a focus on the FDA and EMA agencies, it identifies the regulatory compliance requirements ...

This course features the most robust evidence, best practices, and guiding principles. Content is based on DiMe-generated research and other high-quality sources such as relevant regulatory guidance.

Diagnostics' Role in Medicine Today introduces the ever-expanding molecular diagnostics industry. This class defines the groundbreaking field of qualitative and quantitative biomarker measurements.

Join Thermo Fisher Scientific for an exclusive webinar introducing a transformative approach to biologics development and clinical scale-up. Their "Path to IND for Biologics" method accelerates the ...

Diagnostic Measurements Primer unravels the importance of direct and indirect measurements and their vital role in obtaining regulatory approval. This class begins with the art of constructing and ...

A detailed review of content do's and don'ts including comparative/superiority, charts/graphs, competitor information, “cherry-picking”, disclaimers, references ...

A comprehensive review of the Do's and Don'ts for Digital Tactics: covers drug and medical device advertising, blogging, chat rooms, discussion forums, Facebook and Twitter, links, search (paid and ...